Free Newsletter
Ranbaxy blueprints new facilities
Indian generics maker Ranbaxy Laboratories says it's set to plunk down more than half a million dollars on new healthcare facilities in the Punjab area of India, including hospitals and medical institutes.
The company already has proposed establishing a special tax zone in Mohali, Punjab, where it would invest $65 million in production facilities. There, it plans to ramp up manufacturing, churning out 10 million tablets over the next two years.
- here's the report from India's Economic Times
Related Articles:
Indian court spurns Novartis on patent challenge. Report
India's biotech future is bright. Report
India ramps up biotech funding. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: